Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Reported targets & pathways GHRH receptor Ghrelin / GHS-R1a receptor Pituitary somatotroph GH release IGF-1 axis Selected research Published studies on CJC-1295 + Ipamorelin Blend Peer-reviewed references for further reading
Mod GRF 1-29 does not keep GH and IGF-1 levels constantly elevated for an extended period, so the theoretical concerns linked to prolonged GH and IGF-1 elevation, including insulin sensitivity changes, are generally considered lower with the no-DAC version than the DAC version
It is the easiest to access for self-injection
10 July 2023
US$ 27.87
US$ 23.26
US$ 23.84
US$ 28.58
US$ 23.36
US$ 27.88
US$ 22.02
